MALIGNANT BEHAVIOR AND CELLULAR ANTIGEN EXPRESSION
MALIGNANT BEHAVIOR AND CELLULAR ANTIGEN EXPRESSION
批准号:
3163864
负责人:
GEORGE KLEIN
金额:
$9.32万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1980
资助国家:
美国
项目状态:
已结题
起止时间:
1980-01-01 至 1986-06-30
关键词:
Burkitt's lymphoma Epstein Barr virus L cell cell differentiation cell fusion cell transformation chromosome disorders chromosome translocation clone cells cytogenetics gene expression genetic manipulation genetic mapping human tissue hybrid cells immune response genes immunogenetics immunoglobulin genes linkage mapping lymphoma molecular oncology murine leukemia virus neoplasm /cancer genetics neoplasm /cancer immunology oncogenes oncogenic virus sarcoma surface antigens tumor antigens viral carcinogenesis virus antigen xenotransplantation
中文摘要
细胞遗传学研究:
(1)发现一种新的MPC相关易位类型。滑雪道
携带12号染色体的片段发生了偏着丝粒倒位。这个
倒置片段被移位到15号染色体上。
15号染色体是C-myc定位的D带。
(2)通过对c-myc和IgH进行分类,确定了c-myc和IgH的定位
MPC相关的t(12;15)易位染色体及其DNA杂交
并有相关的调查。C-myc的取向为着丝粒5‘-3’-端粒
IgH为着丝粒-CH-VH-端粒。
(3)inv.Rb(6;15)染色体已证实
携带kappa基因的6号染色体片段被转位到
MPC相关变异易位中的15号染色体并列
以C-myc为尾巴到头部的时尚。
(4)t(15;6)染色体上基因的顺序为着丝粒-5‘-c-myc-3’
PVT-1-CK-端粒。
(5)6号染色体上的Ig-kappa定位也已确定:
着丝粒VK-CK-端粒。
分子研究:
(1)ABPC 45缺失MPC的分子分析显示
C-myc基因参与了多种易位/重组事件
这将癌基因置于IgH链基因增强子的控制之下。
(2)在大鼠中,c-myc基因已被分配到7号染色体上。
将免疫球蛋白重链和kappa轻链基因定位到染色体上
分别为6和4。6号和7号染色体参与了相互作用
自发性大鼠的染色体易位特征
免疫细胞瘤。我们已经证明了染色体上的断裂点
7号染色体位于c-myc癌基因编码区之外。
(3)我们发现,将前病毒DNA插入附近
C-myc和其他15号染色体(c-sis、int-1、mlvi-1、mlvi-2)或
17号染色体(Pim-1)相关癌基因是一种罕见的癌基因。
McF和MoMuLV病毒诱导小鼠T细胞淋巴瘤/白血病和IS
与15-三体无关。
(4)我们已经证明在人浆细胞白血病中c-myc
癌基因扩增25到30倍,其中20倍增长
转录活性。(M)
英文摘要
Cytogenetic Studies:
(1)\A new type of MPC-associated translocation was identified. The IgH
carrying chromosome 12 segment underwent a paracentric inversion. The
inverted segment was translocated onto chromosome 15. The breakpoint on
chromosome 15 is band D where the c-myc was mapped.
(2)\The orientation of c-myc and IgH was determined by sorting the
MPC-associated t(12;15) translocation chromosome and hybridizing its DNA
with relevant probes. The orientation c-myc is centromere 5' -\3'-telomere
and that of IgH is centromere-CH-VH-telomere.
(3)\In situ hybridization on inv. Rb(6;15) chromosome has established that
the chromosome 6 segment that carries the kappa gene is translocated onto
chromosome 15 in the MPC-associated variant translocation and is juxtaposed
to c-myc in a tail to head fashion.
(4)\The order of genes on the t(15;6) chromosome is centromere-5'-c-myc-3'
pvt-1-CK-telomere.
(5)\The orientation Ig-kappa on chromosome 6 was also established:
centromere VK-CK-telomere.
Molecular Studies:
(1)\The molecular analysis of the ABPC 45 deletion MPC revealed that the
c-myc gene has been involved in multiple translocation/recombination events
which placed the oncogene under the control of the IgH chain gene enhancer.
(2)\In the rat, the c-myc gene has been assigned to chromosome 7. We have
mapped the immunoglobulin heavy and kappa light chain genes to chromosomes
6 and 4, respectively. Chromosomes 6 and 7 take part in the reciprocal
chromosomal translocation characteristic to the spontaneous rat
immunocytomas. We have demonstrated that the chromosomal breakpoints on
the chromosome 7 fall outside the coding region of the c-myc oncogene.
(3)\We have found that the insertion of the proviral DNA into the vicinity
of c-myc and other chromosome 15 (c-sis, int-1, Mlvi-1, Mlvi-2) or
chromosome 17 (pim-1) associated oncogenes is an infrequent event in the
MCF and MoMuLV virus induced murine T-cell lymphoma/leukemia and is
independent of 15-trisomy.
(4)\We have demonstrated that in human plasma cell leukemia the c-myc
oncogene is amplified 25 to 30 fold, with a 20-fold increase in
transcriptional activity. (M)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EB-VIRAL IN LATENCY--TRANSFORMATION AND IMMUNE ESCAPE
-
批准号:3197030
-
项目类别:
-
资助金额:$9.46万
-
财政年份:1990
-
负责人:GEORGE KLEIN
-
依托单位:
EB-VIRAL IN LATENCY--TRANSFORMATION AND IMMUNE ESCAPE
-
批准号:3197033
-
项目类别:
-
资助金额:$9.84万
-
财政年份:1990
-
负责人:GEORGE KLEIN
-
依托单位:
EB-VIRAL IN LATENCY--TRANSFORMATION AND IMMUNE ESCAPE
-
批准号:3197032
-
项目类别:
-
资助金额:$9.46万
-
财政年份:1990
-
负责人:GEORGE KLEIN
-
依托单位:
IMMUNE EFFECTOR MECHANISMS IN EBV CARRYING PATIENTS
-
批准号:3169170
-
项目类别:
-
资助金额:$12.65万
-
财政年份:1981
-
负责人:GEORGE KLEIN
-
依托单位:
IMMUNE EFFECTOR MECHANISMS IN EBV CARRYING PATIENTS
-
批准号:3169165
-
项目类别:
-
资助金额:$12.08万
-
财政年份:1981
-
负责人:GEORGE KLEIN
-
依托单位:
EBNA AND OTHER VIRAL PRODUCTS IN EBV TRANSFORMED CELLS
-
批准号:3168116
-
项目类别:
-
资助金额:$7.97万
-
财政年份:1981
-
负责人:GEORGE KLEIN
-
依托单位:
EBNA AND OTHER VIRAL PRODUCTS IN EBV TRANSFORMED CELLS
-
批准号:3168117
-
项目类别:
-
资助金额:$7.57万
-
财政年份:1981
-
负责人:GEORGE KLEIN
-
依托单位:
EBNA AND OTHER VIRAL PRODUCTS IN EBV TRANSFORMED CELLS
-
批准号:3168122
-
项目类别:
-
资助金额:$7.75万
-
财政年份:1981
-
负责人:GEORGE KLEIN
-
依托单位:
IMMUNE EFFECTOR MECHANISMS IN EBV CARRYING PATIENTS
-
批准号:3169162
-
项目类别:
-
资助金额:$11.7万
-
财政年份:1981
-
负责人:GEORGE KLEIN
-
依托单位:
IMMUNE EFFECTOR MECHANISMS IN EBV CARRYING PATIENTS
-
批准号:3169166
-
项目类别:
-
资助金额:$12.81万
-
财政年份:1981
-
负责人:GEORGE KLEIN
-
依托单位:
IMMUNE EFFECTOR MECHANISMS IN EBV CARRYING PATIENTS
-
批准号:3169160
-
项目类别:
-
资助金额:$11.7万
-
财政年份:1981
-
负责人:GEORGE KLEIN
-
依托单位:
IMMUNE EFFECTOR MECHANISMS IN EBV CARRYING PATIENTS
-
批准号:3169169
-
项目类别:
-
资助金额:$12.17万
-
财政年份:1981
-
负责人:GEORGE KLEIN
-
依托单位:
EBNA AND OTHER VIRAL PRODUCTS IN EBV TRANSFORMED CELLS
-
批准号:3168121
-
项目类别:
-
资助金额:$7.72万
-
财政年份:1981
-
负责人:GEORGE KLEIN
-
依托单位:
EBNA AND OTHER VIRAL PRODUCTS IN EBV TRANSFORMED CELLS
-
批准号:3168120
-
项目类别:
-
资助金额:$8.5万
-
财政年份:1981
-
负责人:GEORGE KLEIN
-
依托单位:
IMMUNE EFFECTOR MECHANISMS IN EBV CARRYING PATIENTS
-
批准号:3169167
-
项目类别:
-
资助金额:$11.92万
-
财政年份:1981
-
负责人:GEORGE KLEIN
-
依托单位:
EBNA AND OTHER VIRAL PRODUCTS IN EBV TRANSFORMED CELLS
-
批准号:3168119
-
项目类别:
-
资助金额:$8.02万
-
财政年份:1981
-
负责人:GEORGE KLEIN
-
依托单位:
IMMUNE EFFECTOR MECHANISMS IN EBV CARRYING PATIENTS
-
批准号:3169168
-
项目类别:
-
资助金额:$11.97万
-
财政年份:1981
-
负责人:GEORGE KLEIN
-
依托单位:
IMMUNE EFFECTOR MECHANISMS IN EBV CARRYING PATIENTS
-
批准号:3169159
-
项目类别:
-
资助金额:$12.0万
-
财政年份:1981
-
负责人:GEORGE KLEIN
-
依托单位:
MALIGNANT BEHAVIOR AND CELLULAR ANTIGEN EXPRESSION
-
批准号:3163867
-
项目类别:
-
资助金额:$11.29万
-
财政年份:1980
-
负责人:GEORGE KLEIN
-
依托单位:
MALIGNANT BEHAVIOR AND CELLULAR ANTIGEN EXPRESSION
-
批准号:3163862
-
项目类别:
-
资助金额:$2.33万
-
财政年份:1980
-
负责人:GEORGE KLEIN
-
依托单位:
海外基金